FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1576729511> ?p ?o ?g. }

• W1576729511 endingPage "29" @default.
• W1576729511 startingPage "22" @default.
• W1576729511 abstract "Effectiveness of 5-HT3 receptor antagonists in preventing cyclophosphamide-induced emesis suggests that it is mediated by serotonin release. Since urinary 5-hydroxyindoleacetic acid (5-HIAA) is not significantly increased, the mechanism of emesis induction remains poorly understood, and the usefulness of these drugs in late-onset emesis prevention remains controversial. In this randomised, double-blind, and placebo-controlled trial, 139 chemotherapy-naïve breast cancer patients received intravenous chemotherapy combinations containing cyclophosphamide at doses ≥500 mg/m2. Total antiemetic control was the primary efficacy parameter. On day 0 all patients received intravenous granisetron (3 mg) prior to chemotherapy. On day 1 patients were randomly assigned either to oral granisetron (1 mg bid) or to placebo, for a 2-day course. Patients remained hospitalised during the study period. Rescue therapy (up to 2 doses of i.v. granisetron 3 mg) was promptly administered should there be a second episode of vomiting. Twenty-four hour urine samples were collected on days −1 to +2, for analysis of 5-HIAA excretion. Relative to the control group, significantly more patients in the oral granisetron group experienced total control of emesis on day 1 (67% versus 49%; p=0.04), on day 2 (76% versus 52%; p<0.01), and on days 1–2 (60% versus 42%; p=0.04). Excretion of 5-HIAA was significantly increased on day 0, day 1 and day 2 compared to levels on day −1 (p<0.01 for all paired comparisons). The type of chemotherapy administered and the patient's history of vomiting were the variables influencing the total control of emesis. Oral granisetron provided high rates of effective and safe control of late-onset emesis induced by cyclophosphamide-based chemotherapy. Urinary excretion of 5-HIAA was significantly increased during the entire emesis period." @default.
• W1576729511 created "2016-06-24" @default.
• W1576729511 creator A5005025032 @default.
• W1576729511 creator A5020164600 @default.
• W1576729511 creator A5023576532 @default.
• W1576729511 creator A5025203498 @default.
• W1576729511 creator A5037480131 @default.
• W1576729511 creator A5039091564 @default.
• W1576729511 creator A5044467628 @default.
• W1576729511 creator A5071202334 @default.
• W1576729511 creator A5074540615 @default.
• W1576729511 creator A5075473514 @default.
• W1576729511 creator A5077572513 @default.
• W1576729511 creator A5087560198 @default.
• W1576729511 date "2004-01-01" @default.
• W1576729511 modified "2023-10-15" @default.
• W1576729511 title "Anti-emetic efficacy of oral granisetron in the total control of late-onset emesis induced by cyclophosphamide-containing chemotherapy" @default.
• W1576729511 cites W1881601848 @default.
• W1576729511 cites W191903215 @default.
• W1576729511 cites W1938296075 @default.
• W1576729511 cites W1964624425 @default.
• W1576729511 cites W1964846430 @default.
• W1576729511 cites W1968317017 @default.
• W1576729511 cites W1971233044 @default.
• W1576729511 cites W1976243132 @default.
• W1576729511 cites W1977572327 @default.
• W1576729511 cites W1981429116 @default.
• W1576729511 cites W1988008306 @default.
• W1576729511 cites W1994702038 @default.
• W1576729511 cites W1996635168 @default.
• W1576729511 cites W2000606488 @default.
• W1576729511 cites W2003064028 @default.
• W1576729511 cites W2009336156 @default.
• W1576729511 cites W2011252221 @default.
• W1576729511 cites W2026859749 @default.
• W1576729511 cites W2027313508 @default.
• W1576729511 cites W2048136430 @default.
• W1576729511 cites W2055282927 @default.
• W1576729511 cites W2060256092 @default.
• W1576729511 cites W2072171815 @default.
• W1576729511 cites W2072980994 @default.
• W1576729511 cites W2077643759 @default.
• W1576729511 cites W2081439775 @default.
• W1576729511 cites W2095993002 @default.
• W1576729511 cites W2104277553 @default.
• W1576729511 cites W2118259237 @default.
• W1576729511 cites W2125540170 @default.
• W1576729511 cites W2136660718 @default.
• W1576729511 cites W2145943311 @default.
• W1576729511 cites W2176155345 @default.
• W1576729511 cites W2285198716 @default.
• W1576729511 cites W2341319633 @default.
• W1576729511 cites W2405598008 @default.
• W1576729511 cites W2411236039 @default.
• W1576729511 cites W4253658462 @default.
• W1576729511 doi "https://doi.org/10.1007/bf02710298" @default.
• W1576729511 hasPublicationYear "2004" @default.
• W1576729511 type Work @default.
• W1576729511 sameAs 1576729511 @default.
• W1576729511 citedByCount "1" @default.
• W1576729511 crossrefType "journal-article" @default.
• W1576729511 hasAuthorship W1576729511A5005025032 @default.
• W1576729511 hasAuthorship W1576729511A5020164600 @default.
• W1576729511 hasAuthorship W1576729511A5023576532 @default.
• W1576729511 hasAuthorship W1576729511A5025203498 @default.
• W1576729511 hasAuthorship W1576729511A5037480131 @default.
• W1576729511 hasAuthorship W1576729511A5039091564 @default.
• W1576729511 hasAuthorship W1576729511A5044467628 @default.
• W1576729511 hasAuthorship W1576729511A5071202334 @default.
• W1576729511 hasAuthorship W1576729511A5074540615 @default.
• W1576729511 hasAuthorship W1576729511A5075473514 @default.
• W1576729511 hasAuthorship W1576729511A5077572513 @default.
• W1576729511 hasAuthorship W1576729511A5087560198 @default.
• W1576729511 hasConcept C141071460 @default.
• W1576729511 hasConcept C142724271 @default.
• W1576729511 hasConcept C204787440 @default.
• W1576729511 hasConcept C27081682 @default.
• W1576729511 hasConcept C2776694085 @default.
• W1576729511 hasConcept C2776755627 @default.
• W1576729511 hasConcept C2777170512 @default.
• W1576729511 hasConcept C2777452722 @default.
• W1576729511 hasConcept C2780852908 @default.
• W1576729511 hasConcept C2780884295 @default.
• W1576729511 hasConcept C42219234 @default.
• W1576729511 hasConcept C71924100 @default.
• W1576729511 hasConceptScore W1576729511C141071460 @default.
• W1576729511 hasConceptScore W1576729511C142724271 @default.
• W1576729511 hasConceptScore W1576729511C204787440 @default.
• W1576729511 hasConceptScore W1576729511C27081682 @default.
• W1576729511 hasConceptScore W1576729511C2776694085 @default.
• W1576729511 hasConceptScore W1576729511C2776755627 @default.
• W1576729511 hasConceptScore W1576729511C2777170512 @default.
• W1576729511 hasConceptScore W1576729511C2777452722 @default.
• W1576729511 hasConceptScore W1576729511C2780852908 @default.
• W1576729511 hasConceptScore W1576729511C2780884295 @default.
• W1576729511 hasConceptScore W1576729511C42219234 @default.
• W1576729511 hasConceptScore W1576729511C71924100 @default.
• W1576729511 hasIssue "1" @default.

• next